| NDC Code | 52427-575-30 |
|---|
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-575-30) |
|---|
| Product NDC | 52427-575 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Forfivo |
|---|
| Proprietary Name Suffix | Xl |
|---|
| Non-Proprietary Name | Bupropion Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20170515 |
|---|
| End Marketing Date | 20250101 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA022497 |
|---|
| Manufacturer | Almatica Pharma Inc. |
|---|
| Substance Name | BUPROPION HYDROCHLORIDE |
|---|
| Strength | 450 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA] |
|---|